Tulane Home Tulane Shield logo linking to site home page

Brain Clinical Trials

NRG BN007
A Randomized Phase II/III Open Label Study of Ipilimumab and Nivolumab Versus Temeozolomide in Patients With Newly Diagnosed MGMT (Tumor o-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
More Information